Treatment of methyl 2,3-anhydro-4,6-O-benzylidene-α-D-alloside with the anion derived from trimethyl(prop-1-ynyl)silane, allylmagnesium chloride or isobutenylmagnesium chloride introduces a three- or four- carbon substituent at C2 of the sugar. In each case, a hydroboration-oxidation sequence helps convert the centre of unsaturation in the new substituent into a carboxylic acid residue. Subsequent manipulations allow the introduction ofanother carbon at C6 of the sugar to give a highly functionalized precursor to the C1-C9 fragment of tylonolide, the aglycon of the antibiotic tylosin. Attempts at the introduction of an axial methyl group at C4 of the extended sugar also described.
将 2,3-脱水-4,6-O-亚苄基-α-D-阿洛糖甲基与三甲基(丙-1-炔基)硅烷、烯丙基氯化镁或异丁烯基氯化镁衍生的阴离子进行处理,可在糖的 C2 处引入三碳或四碳取代基。在每种情况下,氢硼氧化顺序都有助于将新取代基中的不饱和中心转化为羧酸残基。随后的操作允许在糖的 C6 处引入另一个碳,从而得到高度官能化的前体,形成泰诺内酯的 C1-C9 片段,即抗生素泰罗菌素的苷元。此外,还介绍了在扩展糖的 C4 处引入轴向甲基的尝试。